跳至主要内容
临床试验/NCT07017153
NCT07017153已完成不适用

Evaluation of the Impact of Decision Aids on Treatment Choices in Patients With Arterial Hypertension: A Pilot Study

Medizinische Hochschule Brandenburg Theodor Fontane2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年2月27日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60
试验地点
2
主要终点
Patient-perceived usefulness of hypertension decision aids

研究概览

简要总结

Background: Arterial hypertension is a major global health problem with a leading cause of premature death and a major risk factor for cardiovascular disease. Despite its prevalence, blood pressure control remains suboptimal, requiring effective treatment and patient engagement strategies. With the increasing emphasis on person-centered care, healthcare professionals and patients are moving toward shared decision-making (SDM), which is defined as an approach to collaboratively making health decisions in line with recent evidence and patient preferences and values. Patient decision aids (PDAs) are tools designed to involve patients in treatment decisions by providing clear information about options, benefits and risks, while helping them to clarify personal values. These tools have been shown to improve decision quality, adherence and health outcomes.

Methods: This pilot study aims to evaluate the practical utility of two PDAs with different formats for antihypertensive therapy from the patient's perspective. Adult patients (≥ 18 years) with hypertension admitted to a university hospital will be randomized to use one of the two PDAs displayed on a tablet. After viewing the PDA, participants will complete a questionnaire assessing their knowledge, risk perception, preferences, and involvement in decision-making. Descriptive statistics will be used to analyze the data.

Expected results: The study anticipates that the PDAs will increase patients knowledge of treatment options, support value clarification and improve engagement in SDM. These findings will inform the design of a larger randomized controlled trial to optimize PDA formats for hypertension management.

详细描述

Detailed Description

  1. INTRODUCTION Arterial hypertension is one of the most important modifiable risk factors for cardiovascular disease and a leading cause of premature death worldwide. Despite effective therapies, only about 20% of the 1.28 billion adults worldwide have their blood pressure under control, increasing the risk of major cardiovascular events. This highlights the need for personalized treatment strategies and patient engagement. Shared decision-making (SDM) is a key approach to collaborative decision-making between patients and healthcare professionals, aimed at tailoring treatment options and goals to patients' needs and preferences, as emphasized in the ESC 2024 guidelines. Patient decision aids (PDAs) are tools designed to support SDM by providing clear information about treatment options, risks and benefits, while helping patients to clarify their preferences and values. Evidence suggests that PDAs improve the quality of decisions, promote adherence and have a positive impact on hypertension outcomes.
  2. BACKGROUND AND RATIONALE Hypertension management requires a patient-centered approach, as treatment goals, such as achieving a target systolic blood pressure of 120-129 mmHg, should be adapted to individual tolerance and well-being. The 2024 ESC guidelines highlight the importance of SDM. PDAs can help overcome challenges. These tools prepare patients to make value-based decisions without replacing medical consultations. Despite their potential benefits, there is limited evidence on which PDA format and features are most effective for hypertensive patients. This pilot study aims to address this gap by evaluating different PDA formats to identify those that best improve patient understanding, knowledge and value clarification. The results will inform the design of optimized PDAs for clinical use in hypertension management and contribute to overcoming existing barriers to SDM in practice.
  3. OBJECTIVES The aim of this pilot study is to evaluate PDAs for antihypertensive therapy from the patient's perspective to answer the following research question: Which format of PDA is most useful in practice to support SDM in hypertension management?

Specifically, the study aims to:

  1. Evaluate which design features of two different PDA formats are most effective improving patients knowledge of hypertension management regarding the available treatment options, including their benefits and risks.
  2. Evaluate how PDAs support patients in clarifying their personal values and preferences regarding treatment choices.
  3. Investigate whether the use of PDAs increases patients involvement in SDM. Findings will inform the development of optimized PDA formats that can improve patient adherence, enhance decision quality, and ultimately contribute to better clinical outcomes in hypertension care.
  4. METHODS Study design: Randomized controlled pilot study to assess which format of PDAs is most useful in supporting SDM about antihypertensive therapy and to identify potential challenges and refine the methodology for a future large-scale trial. Participants: the study will include a minimum of 60 adult patients (≥ 18 years) diagnosed with arterial hypertension of any grade and regardless of the time of diagnosis. Patients need to be treated at the Department of Internal Medicine I, University Hospital Brandenburg an der Havel, Germany. Eligible participants will be invited to participate regardless of their reason for hospitalization, provided they meet the inclusion criteria. Randomization: Participants will be randomly allocated to one of two intervention arms using a computer-generated allocation sequence. Intervention arm A:

Participants will use the decision aid "How so I control my blood pressure? Lifestyle options and choices of medicines." (https://www.nice.org.uk/guidance/ng136/resources/how-do-i-control-my-blood-pressure-lifestyle-options-and-choice-of-medicines-patient-decision-aid-pdf-6899918221) Intervention arm B: Participants will use the decision aid "Bluthochdruck - Wie Herz-Kreislauf-Erkrankungen vorbeugen?" (engl.: High Blood Pressure - How to prevent cardiovascular disease). (https://entscheidungshilfe.share-to-care.de/bluthochdruck/)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adults (>18 years)
  • •Diagnosed with hypertension (all stages), regardless of primary reason for treatment.
  • •Receiving treatment at the Department of Internal Medicine I, University Hospital Brandenburg an der Havel

排除标准

  • •Patients under 18 years old
  • •Pregnancy-induced hypertension
  • •Patients unable to provide informed consent

研究组 & 干预措施

Patient Decision Aid B

Other

Patients will receive Decision Aid B. Original:

"How Do I Control My Blood Pressure? Lifestyle Options and Choices of Medicines". (NICE 2019. ISBN 978-1-4731-3543-7) German Translation for our Study: "Wie kann ich meinen Bluthochdruck behandeln? Optionen zu Lebensstiländerungen und der Medikamentenwahl"

干预措施: Questionnaire B (Other)

Patient Decision Aid A

Other

Patients will receive Decision Aid A. Original: "Bluthochdruck - Wie Herz-Kreislauf-Erkrankungen vorbeugen?". (SHARE TO CARE, 2025. https://entscheidungshilfe.share-to-care.de/bluthochdruck/ (access: 25.02.2025)) English translation: "Hypertension - How to Prevent Cardiovascular Diseases"

干预措施: Questionnaire A (Other)

结局指标

主要结局

Patient-perceived usefulness of hypertension decision aids

时间窗: Up to 24 weeks

Patient-Perceived Usefulness of the Decision Aid (Measured by a Study-Specific Questionnaire adapted from the Multidimensional Measure of Informed Choice \[MMIC; DOI: 10.1016/S0738-3991(02)00089-7\], assessing relevance, clarity, and ease of use, aligning with questions addressing decision aids for arterial hypertension therapy)

次要结局

  • Knowledge(Up to 24 weeks.)
  • Risk Perception(Up to 24 Weeks)
  • Confidence in decision-making(Up to 24 Weeks)
  • Preparation for decision making(Up to 24 weeks)

研究者

发起方
Medizinische Hochschule Brandenburg Theodor Fontane
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jan Berghold

Medical Student and Doctoral Candidate

Medizinische Hochschule Brandenburg Theodor Fontane

研究点 (2)

Loading locations...

相似试验